|
Volumn 57, Issue 2, 2009, Pages 155-157
|
Pneumatic displacement and intravitreal bevacizumab: A new approach for management of submacular hemorrhage in choroidal neovascular membrane
|
Author keywords
Bevacizumab; Choroidal neovascular membrane; Pneumatic displacement; Submacular hemorrhage
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
BEVACIZUMAB;
MONOCLONAL ANTIBODY;
SULFUR HEXAFLUORIDE;
VASCULOTROPIN A;
ADULT;
AGED;
ARTICLE;
CASE REPORT;
DRUG ANTAGONISM;
FEMALE;
FLUORESCENCE ANGIOGRAPHY;
HUMAN;
INJECTION;
INTRAOCULAR PRESSURE;
MALE;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
OPTICAL COHERENCE TOMOGRAPHY;
PHYSIOLOGY;
PRESSURE;
RETINA HEMORRHAGE;
SUBRETINAL NEOVASCULARIZATION;
VISUAL ACUITY;
VITREOUS BODY;
ADULT;
AGED;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL;
CHOROIDAL NEOVASCULARIZATION;
COMBINED MODALITY THERAPY;
FEMALE;
FLUORESCEIN ANGIOGRAPHY;
HUMANS;
INJECTIONS;
INTRAOCULAR PRESSURE;
MALE;
MIDDLE AGED;
PRESSURE;
RETINAL HEMORRHAGE;
SULFUR HEXAFLUORIDE;
TOMOGRAPHY, OPTICAL COHERENCE;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VISUAL ACUITY;
VITREOUS BODY;
|
EID: 61349170737
PISSN: 03014738
EISSN: 19983689
Source Type: Journal
DOI: 10.4103/0301-4738.45511 Document Type: Article |
Times cited : (16)
|
References (4)
|